510(k) K230104
K230104 is an FDA 510(k) premarket notification submitted by Anthogyr for the device "Anthogyr AXIOM® BL X3 implants, Anthogyr Multi-Unit components for AXIOM® BL". The FDA issued a decision of Substantially Equivalent on October 16, 2023. The device falls under product code DZE (Implant, Endosseous, Root-Form), a Class II device regulated under 21 CFR 872.3640. Anthogyr has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- October 16, 2023
- Date Received
- January 13, 2023
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Implant, Endosseous, Root-Form
- Device Class
- Class II
- Regulation Number
- 872.3640
- Review Panel
- DE
- Submission Type